These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37477162)

  • 1. Upregulation of integrin‑linked kinase enhances tumor progression in gemcitabine‑resistant pancreatic cancer.
    Murase H; Matsuo Y; Denda Y; Nonoyama K; Kato T; Aoyama Y; Hayashi Y; Imafuji H; Saito K; Morimoto M; Ogawa R; Takahashi H; Mitsui A; Kimura M; Takiguchi S
    Oncol Rep; 2023 Sep; 50(3):. PubMed ID: 37477162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquisition of gemcitabine resistance enhances angiogenesis via upregulation of IL‑8 production in pancreatic cancer.
    Imafuji H; Matsuo Y; Ueda G; Omi K; Hayashi Y; Saito K; Tsuboi K; Morimoto M; Koide S; Ogawa R; Hara M; Takahashi H; Takiguchi S
    Oncol Rep; 2019 Jun; 41(6):3508-3516. PubMed ID: 31002348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of integrin-linked kinase in drug resistance of lung cancer.
    Jia Z
    Onco Targets Ther; 2015; 8():1561-5. PubMed ID: 26150729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists.
    Morimoto M; Matsuo Y; Koide S; Tsuboi K; Shamoto T; Sato T; Saito K; Takahashi H; Takeyama H
    BMC Cancer; 2016 May; 16():305. PubMed ID: 27175473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursolic acid promotes apoptosis, autophagy, and chemosensitivity in gemcitabine-resistant human pancreatic cancer cells.
    Lin JH; Chen SY; Lu CC; Lin JA; Yen GC
    Phytother Res; 2020 Aug; 34(8):2053-2066. PubMed ID: 32185829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells.
    Duong HQ; Hwang JS; Kim HJ; Kang HJ; Seong YS; Bae I
    Int J Oncol; 2012 Sep; 41(3):855-61. PubMed ID: 22710732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer.
    Tan Y; Li X; Tian Z; Chen S; Zou J; Lian G; Chen S; Huang K; Chen Y
    Biochem Pharmacol; 2021 Jul; 189():114085. PubMed ID: 32522594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Proteomic Analysis Identifies Key Metabolic Regulators of Gemcitabine Resistance in Pancreatic Cancer.
    Lin Q; Shen S; Qian Z; Rasam SS; Serratore A; Jusko WJ; Kandel ES; Qu J; Straubinger RM
    Mol Cell Proteomics; 2022 Oct; 21(10):100409. PubMed ID: 36084875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Natural Product Parthenolide Inhibits Both Angiogenesis and Invasiveness and Improves Gemcitabine Resistance by Suppressing Nuclear Factor κB Activation in Pancreatic Cancer Cell Lines.
    Denda Y; Matsuo Y; Sugita S; Eguchi Y; Nonoyama K; Murase H; Kato T; Imafuji H; Saito K; Morimoto M; Ogawa R; Takahashi H; Mitsui A; Kimura M; Takiguchi S
    Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursolic acid restores sensitivity to gemcitabine through the RAGE/NF-κB/MDR1 axis in pancreatic cancer cells and in a mouse xenograft model.
    Li ZY; Chen SY; Weng MH; Yen GC
    J Food Drug Anal; 2021 Jun; 29(2):262-274. PubMed ID: 35696208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin facilitates cell death and chemosensitivity through RAGE/PI3K/AKT/mTOR axis in human pancreatic cancer cells.
    Lan CY; Chen SY; Kuo CW; Lu CC; Yen GC
    J Food Drug Anal; 2019 Oct; 27(4):887-896. PubMed ID: 31590760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine potentiates anti-tumor effect of resveratrol on pancreatic cancer via down-regulation of VEGF-B.
    Yang Y; Tian W; Yang L; Zhang Q; Zhu M; Liu Y; Li J; Yang L; Liu J; Shen Y; Qi Z
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):93-103. PubMed ID: 32897433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single-agent fibroblast growth factor receptor-specific inhibitors in pancreatic cancer.
    Lin Q; Serratore A; Perri J; Roy Chaudhuri T; Qu J; Ma WW; Kandel ES; Straubinger RM
    Br J Pharmacol; 2024 May; 181(9):1383-1403. PubMed ID: 37994108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heptadecanoic Acid, an Odd-Chain Fatty Acid, Induces Apoptosis and Enhances Gemcitabine Chemosensitivity in Pancreatic Cancer Cells.
    Kim HY; Moon JY; Cho SK
    J Med Food; 2023 Mar; 26(3):201-210. PubMed ID: 36716276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
    Chaudhary AK; Mondal G; Kumar V; Kattel K; Mahato RI
    Cancer Lett; 2017 Aug; 402():1-8. PubMed ID: 28536008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells.
    Kan S; Koido S; Okamoto M; Hayashi K; Ito M; Kamata Y; Komita H; Nagasaki E; Homma S
    BMC Cancer; 2015 Oct; 15():726. PubMed ID: 26475267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a combination of S-1 and gemcitabine on cell cycle regulation in pancreatic cancer cell lines.
    Morimoto Y; Takeuchi O; Takizawa A; Yoneyama H; Asanuma F; Suzuki Y; Atsuda K; Yamada Y
    Anticancer Drugs; 2012 Jun; 23(5):505-14. PubMed ID: 22334000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway.
    Bu HQ; Luo J; Chen H; Zhang JH; Li HH; Guo HC; Wang ZH; Lin SZ
    Int J Oncol; 2012 Sep; 41(3):949-58. PubMed ID: 22710877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNT1 expression influences proliferation and chemosensitivity in drug-resistant pancreatic cancer cells.
    Bhutia YD; Hung SW; Patel B; Lovin D; Govindarajan R
    Cancer Res; 2011 Mar; 71(5):1825-35. PubMed ID: 21343396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of integrin‑linked kinase gene silencing on microRNA expression in ovarian cancer.
    Yuan D; Zhao Y; Wang Y; Che J; Tan W; Jin Y; Wang F; Li P; Fu S; Liu Q; Zhu W
    Mol Med Rep; 2017 Nov; 16(5):7267-7276. PubMed ID: 28944870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.